Tecfidera

City of Baltimore sues Biogen over allegedly paying PBMs to stave off Tecfidera generic competition
Medical Marketing and Media
Wed, 09/25/24 - 10:19 pm
Biogen
Baltimore
legal
PBMs
generics
competition
MS
Tecfidera
Biogen sued for alleged PBM kickbacks scheme to boost Tecfidera in wake of generics
Fierce Pharma
Wed, 08/21/24 - 11:41 am
Biogen
Tecfidera
legal
kickbacks
PBMs
generics
Europe revokes marketing authorization for generic versions of Biogen's MS drug
Reuters
Tue, 12/19/23 - 10:08 am
Biogen
Tecfidera
MS
multiple sclerosis
Europe
generics
Biogen chalks up a Tecfidera patent win in Europe after losing US protections
Fierce Pharma
Fri, 05/5/23 - 11:50 am
Biogen
Tecfidera
multiple sclerosis
Europe
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Seeking Alpha
Thu, 03/16/23 - 09:44 am
Biogen
EMA
Europe
MS
multiple sclerosis
Tecfidera
generics
Biogen gains prominent ally in bid for Supreme Court to review Tecfidera patent case
Fierce Pharma
Wed, 07/13/22 - 08:17 pm
Biogen
Tecfidera
patents
Supreme Court
Split U.S. appeals court rejects Biogen bid to revive MS drug patent dispute
Reuters
Thu, 03/17/22 - 10:25 am
Biogen
Mylan
Tecfidera
patents
multiple sclerosis
MS
Biogen takes another blow as appeal for Tecfidera patent revival falls short
Fierce Pharma
Tue, 11/30/21 - 11:38 pm
Biogen
Tecfidera
patents
multiple sclerosis
MS
Biogen is running out of safety nets
BioPharma Dive
Thu, 10/22/20 - 10:53 am
Biogen
Vumerity
Tecfidera
Spinraza
aducanumab
Mylan launches first generic to Tecfidera in multiple sclerosis
Seeking Alpha
Wed, 08/19/20 - 09:26 am
Mylan
generics
Tecfidera
Biogen
MS
multiple sclerosis
Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Endpoints
Fri, 07/31/20 - 10:46 am
Biogen
Tecfidera
Mylan
generics
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Mon, 06/22/20 - 08:36 pm
Biogen
Tecfidera
Mylan
patents
generics
MS
multiple sclerosis
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Fierce Pharma
Thu, 06/18/20 - 10:44 am
Biogen
Mylan
Tecfidera
patents
MS
multiple sclerosis
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Motley Fool
Tue, 02/11/20 - 10:36 am
Biogen
Mylan
Alzheimer's disease
patents
Tecfidera
MS
multiple sclerosis
Vumerity
Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Fierce Pharma
Wed, 02/5/20 - 10:25 pm
Biogen
patents
Tecfidera
Mylan
multiple sclerosis
MS
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says
Multiple Sclerosis News Today
Thu, 11/14/19 - 07:35 pm
Biogen
MS
multiple sclerosis
Vumerity
drug pricing
Tecfidera
A new company enters the Tecfidera fight, offering to kill two birds
Endpoints
Tue, 10/22/19 - 10:29 am
Biogen
Tecfidera
MS
flushing
Vitalis Pharmaceuticals
Biogen, wrestling MS rivals, touts 10 year-plus Tecfidera data
Fierce Pharma
Wed, 09/11/19 - 10:26 am
Biogen
Tecfidera
MS
multiple sclerosis
Biogen beats estimates on multiple sclerosis therapy sales Reuters
Yahoo/Reuters
Tue, 07/23/19 - 10:07 am
Biogen
earnings
Tecfidera

Pages